Onvansertib Product Pipeline

Pipeline

Our pipeline opens many attractive opportunities for onvansertib

STATUS

PARTNERS

mCRC / FOLFIRI/bev
Enrolling
mPDAC / Onivyde/5-FU
Enrolling
mCRPC / Abiraterone
Enrolling
mPDAC / Biomarker
Target Q1 '22
Oregon-university
TNBC / Combo w/ Paclitaxel
Development
logo-dana-farber
SCLC / Single Agent
Development
UPMC
CMML / Single Agent
Development
Medulloblastoma / Combo w/ radiation
Development
Ovarian / PARP inhibitors
Development
logo-dana-farber

Looking to partner with us?

Please send inquiries to bd@cardiffoncology.com